Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00023166
Status:
TERMINATED
Last Update Posted:
2005-06-24
First Post:
2001-08-24
Brief Title:
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors Lymphomas
Sponsor:
Enzon Pharmaceuticals Inc
Organization:
Enzon Pharmaceuticals Inc
Study Overview
Official Title:
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors and Lymphomas
Status:
TERMINATED
Status Verified Date:
2004-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Studies of PEG-paclitaxel have been terminated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None